Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine based regimen

被引:0
|
作者
Resnick, I.
Zilberman, I.
Tsirigotis, P.
Aker, M.
Shapira, M. Y.
Bitan, M.
Gesundheit, B.
Amarg, A.
Ackerstein, A.
Samuel, S.
Slaving, S.
Or, R.
机构
[1] Hadassah Med Ctr, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Med Ctr, Jerusalem, Israel
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0366
引用
收藏
页码:132 / 132
页数:1
相关论文
共 50 条
  • [1] Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen
    I B Resnick
    M Aker
    P Tsirigotis
    M Y Shapira
    A Abdul-Hai
    M Bitan
    B Gesundheit
    A Amar
    A Ackerstein
    S Samuel
    S Slavin
    R Or
    [J]. Bone Marrow Transplantation, 2007, 40 : 957 - 964
  • [2] Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity. udarabine-based regimen
    Resnick, I. B.
    Aker, M.
    Tsirigotis, P.
    Shapira, M. Y.
    Abdul-Hai, A.
    Bitan, M.
    Gesundheit, B.
    Amar, A.
    Ackerstein, A.
    Samuel, S.
    Slavin, S.
    Or, R.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 40 (10) : 957 - 964
  • [3] Allogeneic hematopoietic stem cell transplantation for thalassemia major using matched unrelated donors and haploidentical related donors
    Wang Feiyan
    Qu Yuhua
    Jiang Hua
    [J]. 中华医学杂志英文版, 2025, 138 (04)
  • [4] Reduced-toxicity preparative regimen with treosulfan, thiotepa, fludarabine and atg in unrelated allogeneic stem cell transplantation for thalassemia patients
    La Nasa, G.
    Piras, E.
    Vacca, A.
    Caocci, G.
    Ledda, A.
    Atzeni, S.
    Garau, P.
    Mantovani, D.
    Oppi, S.
    Pilo, G.
    De Stefano, P.
    Santarone, S.
    Di, Bartolomeo P.
    Locatelli, F.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 98 - 99
  • [5] Comparison of allogeneic stem cell transplantation results from related or unrelated donors in β-thalassemia major
    Aydogdu, Selime
    Mergen, Azize
    Aksoy, Basak
    Cokluk, Mila N.
    Dikme, Gurcan
    Cipe, Funda
    Fisgin, Tunc
    Bozkurt, Ceyhun
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 570 - 571
  • [6] A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome
    N Kröger
    J Schetelig
    T Zabelina
    W Krüger
    H Renges
    N Stute
    J Schrum
    H Kabisch
    W Siegert
    AR Zander
    [J]. Bone Marrow Transplantation, 2001, 28 : 643 - 647
  • [7] A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome
    Kröger, N
    Schetelig, J
    Zabelina, T
    Krüger, W
    Renges, H
    Stute, N
    Schrum, J
    Kabisch, H
    Siegert, W
    Zander, AR
    [J]. BONE MARROW TRANSPLANTATION, 2001, 28 (07) : 643 - 647
  • [8] Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors
    Bitan, M.
    Or, R.
    Shapira, M. Y.
    Aker, M.
    Resnick, I. B.
    Ackerstein, A.
    Samuel, S.
    Elad, S.
    Slavin, S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (07) : 712 - 718
  • [9] Allogeneic stem cell transplantation from unrelated donor for class 3 β-thalassemia major using reduced-intensity conditioning regimen
    K E Zhu
    J Gu
    T Zhang
    [J]. Bone Marrow Transplantation, 2006, 37 : 111 - 112
  • [10] Allogeneic stem cell transplantation from unrelated donor for class 3 β-thalassemia major using reduced-intensity conditioning regimen
    Zhu, KE
    Gu, J
    Zhang, T
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 (01) : 111 - 112